Sputnik v to the rescue: how russia's covid vaccine may help argentina shield people & economy

IT'S NO GOOD POLITICISING COVID VACCINATION Still, the anti-COVID vaccination issue remains heavily politicised. Russia's Sputnik V was subjected to fierce criticism from US and EU

political observers as soon as it was officially registered. In early September CNBC admitted, however, that Sputnik V shows no adverse effects and creates a substantive antibody response,

citing The Lancet, the world's oldest and most reputable medical journal. Nevertheless, following Hungarian Prime Minister Viktor Orban's announcement on 30 October that Budapest

is negotiating with Russia and China for anti-COVID shots, European Commission spokesman Eric Mamer stated that any coronavirus drugs must comply with the EU standards and undergo special

approval procedures. Some observers have interpreted the statement as a signal to Orban. > "The anti-COVID struggle has been politicised in Argentina early on. > Of course, the 

whole world is no exception to this. But that issue > can also be seen in Argentina internally. The people who are in the > opposition to the Fernandez government have said they are 

against > the vaccination with the Sputnik drug," Viani says, adding that the > major argument cited by these people is that it is 'the Russian > vaccine'." 

"They seem to have a strange and outdated Cold War > perspective of things that no longer correspond to reality." The politicisation of healthcare amid the longstanding pandemic

does no good to anyone, according to the Argentine author. "I think that it is important that some issues, especially those involving health and topics of public interest, should be

left out of the political discussions. The vaccine is an example of that," he concludes. Meanwhile, Russia's Sputnik V vaccine has demonstrated impressive results during the final

Phase 3 trials. On 26 October, Alexander Gintsburg, the head of the Gamaleya Research Centre, specified in an interview with the broadcaster Rossiya 24 that 85% of those administering the

drug had experienced no side effects. Unlike other vaccines, Russia's Sputnik V is administered in two shots to boost its efficiency. In addition to this, in mid-October Russia's

second vaccine, EpiVacCorona, was rolled out by Russia's State Research Centre of Virology and Biotechnology Vector.